HIV molecular immunology database
| Patient Code | 014A-004 |
|---|---|
| Patient Sex | Male |
| Risk Factor | Sex with male (SM) |
| Infection Country | US |
| Infection City | |
| Infection Year | |
| HLA Type | A*02:01, A*11:01, B*40:02, B*51:01, C*02:02, C*14:02 |
| Patient Ethnicity | White |
| Progression | |
| Species | human |
| Patient Note | Subject 014A-004, 35 years old, who participated in a vaccine trial, acquired HIV within 242 days of administration of vaccine vCP205, 4 times. Response to epitopes Pol TAFTIPSI, Gag CTERQANFL, Gag SLYNTVATL and Nef AVDLSHFLK by EliSpot was 210, 70, 149 and 740 SFC/106 PBMC, 46d post-infection (dpi). [Horton2006a, PMID: 16973582]. Additional HLA-C alleles from authors (pers comm., J.McNevin, 2021). |
| CTL CD8+ Records | 54940, 54941, 54942, 54943, 62526 |
| T-Helper CD4+ Records | |
| Antibody Records | |
| Sequence Database Patient ID Record |